VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Thursday, January 1, 2026
Stock Comparison
Parker-Hannifin Corporation vs Sanofi
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Parker-Hannifin Corporation
PH · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Parker-Hannifin Corporation's moat claims, evidence, and risks.
View PH analysisSanofi
SAN · Euronext Paris
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Comparison highlights
- Moat score gap: Sanofi leads (74 / 100 vs 71 / 100 for Parker-Hannifin Corporation).
- Segment focus: Parker-Hannifin Corporation has 2 segments (68.8% in Diversified Industrial); Sanofi has 3 segments (79.8% in Pharma (Prescription Medicines)).
- Primary market structure: Competitive vs Oligopoly. Pricing power: Moderate vs Moderate.
- Moat breadth: Parker-Hannifin Corporation has 5 moat types across 2 domains; Sanofi has 5 across 3.
Primary market context
Parker-Hannifin Corporation
Diversified Industrial
Motion and control components & systems (industrial and mobile applications)
Global
OEMs and industrial distributors/aftermarket channels
Component and system designer/manufacturer with aftermarket support
68.8%
Sanofi
Pharma (Prescription Medicines)
Branded prescription pharmaceuticals (immunology, rare disease, neurology, oncology, general medicines)
Global
Patients via payers/providers and channel partners (wholesalers, pharmacies, hospitals)
Research-based drug developer, manufacturer, and marketer
79.8%
Side-by-side metrics
Moat coverage
Shared moat types
Parker-Hannifin Corporation strengths
Sanofi strengths
Segment mix
Parker-Hannifin Corporation segments
Full profile >Diversified Industrial
Competitive
Aerospace Systems
Oligopoly
Sanofi segments
Full profile >Pharma (Prescription Medicines)
Oligopoly
Vaccines
Oligopoly
Opella (Consumer Healthcare - Sanofi minority stake)
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.